Marketing-authorisation holder Β· United Kingdom
Biogen Idec Ltd
3 medicines in 2 countries, as authorisation holder.
Loading your pageβ¦
Loading your pageβ¦
Marketing-authorisation holder Β· United Kingdom
3 medicines in 2 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AVONEX 30micrograme/0.5ml30micrograme/0.5ml Β· Sol. inj. in stilou injector (pen) preumplut | Interferon beta-1a | Romania | unknown | |
| FAMPYRA10mg Β· Compr. elib. prel. | Fampridine | Romania | unknown | |
| Zinbryta | Daclizumab | EU (EMA) | Withdrawn | 2016 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Romania | 2 | 0 | 2 | CompaniesAll medicines |
| European Union (EMA) | 1 | 0 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Ministerul SΔnΔtΔΘii, Catalogul public naΕ£ional al preΕ£urilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.